Apertura Gene Therapy

VELIZY-VILLACOUBLAY, France, July 23, 2026 Dassault Systèmes has expanded its 3DEXPERIENCE AI-native agentic platform with the launch of three...

NEW YORK, N.Y., July 23, 2026 Apertura Gene Therapy has announced its participation in a consortium selected to receive...

NEW YORK | July 9, 2026 Apertura Gene Therapy, a biotechnology company developing next-generation adeno-associated virus (AAV) capsids for...